Shi et al. [82] reported that andrographolide can inhibit human colorectal carcinoma (CRC) Lovo cell growth by G1–S phase arrest and induce the expression of cell-cycle inhibitory proteins p53, p21, and p16. Here, TP53 is linked to colorectal carcinoma.